| Attribute |
Value |
| 52 Week Change |
-0.7646444 |
| Address1 |
Harvard Square |
| Address2 |
One Mifflin Place Suite 400 |
| All Time High |
138,156,000.0 |
| All Time Low |
1.75 |
| Ask |
2.79 |
| Ask Size |
2 |
| Average Daily Volume10 Day |
16,220 |
| Average Daily Volume3 Month |
27,370 |
| Average Volume |
27,370 |
| Average Volume10Days |
16,220 |
| Bid |
2.21 |
| Bid Size |
1 |
| Book Value |
0.961 |
| City |
Cambridge |
| Compensation As Of Epoch Date |
1,767,139,200 |
| Country |
United States |
| Crypto Tradeable |
0 |
| Currency |
USD |
| Current Price |
2.24 |
| Current Ratio |
4.273 |
| Custom Price Alert Confidence |
HIGH |
| Date Short Interest |
1,782,777,600 |
| Day High |
2.24 |
| Day Low |
2.2 |
| Debt To Equity |
0.28 |
| Display Name |
Vyome |
| Earnings Timestamp End |
1,763,064,000 |
| Earnings Timestamp Start |
1,763,064,000 |
| Ebitda |
-3,666,912 |
| Ebitda Margins |
0.0 |
| Enterprise To Ebitda |
-2.249 |
| Enterprise To Revenue |
53.99 |
| Enterprise Value |
8,245,614 |
| Eps Trailing Twelve Months |
-1.55 |
| Esg Populated |
0 |
| Exchange |
NCM |
| Exchange Data Delayed By |
0 |
| Exchange Timezone Name |
America/New_York |
| Exchange Timezone Short Name |
EDT |
| Fifty Day Average |
2.1517 |
| Fifty Day Average Change |
0.08829999 |
| Fifty Day Average Change Percent |
0.041037314 |
| Fifty Two Week Change Percent |
-76.46444 |
| Fifty Two Week High |
18.6 |
| Fifty Two Week High Change |
-16.36 |
| Fifty Two Week High Change Percent |
-0.8795699 |
| Fifty Two Week Low |
1.75 |
| Fifty Two Week Low Change |
0.49 |
| Fifty Two Week Low Change Percent |
0.28 |
| Fifty Two Week Range |
1.75 - 18.6 |
| Financial Currency |
USD |
| First Trade Date Milliseconds |
1,475,760,600,000 |
| Float Shares |
3,254,351 |
| Free Cashflow |
4,116,844 |
| Full Exchange Name |
NasdaqCM |
| Full Time Employees |
9 |
| Gmt Off Set Milliseconds |
-14,400,000 |
| Gross Margins |
0.53034997 |
| Gross Profits |
80,997 |
| Has Pre Post Market Data |
1 |
| Held Percent Insiders |
0.52881 |
| Held Percent Institutions |
0.0152199995 |
| Implied Shares Outstanding |
7,018,528 |
| Industry |
Biotechnology |
| Industry Disp |
Biotechnology |
| Industry Key |
biotechnology |
| Is Earnings Date Estimate |
1 |
| Language |
en-US |
| Last Fiscal Year End |
1,767,139,200 |
| Last Split Date |
1,755,216,000 |
| Last Split Factor |
1:4 |
| Long Business Summary |
Vyome Holdings, Inc., a clinical-stage specialty pharmaceutical company, develops therapeutic products targeting immuno-inflammatory and rare diseases in the United States. It operates through Pharmaceutical and Biotechnology segments. The company's lead product candidate VT-1953, a dual DNA Gyrase/Topoisomerase inhibitor and immunomodulator in a topical gel formulation that is in phase 2 clinical stage for the treatment of bacterial conjunctivitis. It also develops VT-1908, a topical eye drop is an inosine 5'-monophosphate dehydrogenase enzyme inhibitor to treat immunoinflammatory conditions of the eye; and VB-1953, which is in phase 2 clinical stage for the treatment of inflammatory acne. In addition, the company develops antifungal products using the molecular replacement therapy (MRT) platform. It has a collaboration and license agreement with Sun Pharma Laboratories Limited to develop and commercialize next-generation antifungal products. The company is based in Cambridge, Massachusetts. |
| Long Name |
Vyome Holdings, Inc. |
| Market |
us_market |
| Market Cap |
15,721,503 |
| Market State |
PRE |
| Max Age |
86,400 |
| Message Board Id |
finmb_115222623 |
| Most Recent Quarter |
1,774,915,200 |
| Net Income To Common |
-10,930,943 |
| Next Fiscal Year End |
1,798,675,200 |
| Non Diluted Market Cap |
15,791,688 |
| Number Of Analyst Opinions |
2 |
| Open |
2.22 |
| Operating Cashflow |
-4,981,284 |
| Operating Margins |
-35.76778 |
| Payout Ratio |
0.0 |
| Phone |
973-832-8147 |
| Previous Close |
2.25 |
| Price Hint |
4 |
| Price To Book |
2.3309052 |
| Price To Sales Trailing12 Months |
102.94062 |
| Profit Margins |
0.0 |
| Quick Ratio |
4.168 |
| Quote Source Name |
Nasdaq Real Time Price |
| Quote Type |
EQUITY |
| Recommendation Key |
none |
| Region |
US |
| Regular Market Change |
-0.00999999 |
| Regular Market Change Percent |
-0.444444 |
| Regular Market Day High |
2.24 |
| Regular Market Day Low |
2.2 |
| Regular Market Day Range |
2.2 - 2.24 |
| Regular Market Open |
2.22 |
| Regular Market Previous Close |
2.25 |
| Regular Market Price |
2.24 |
| Regular Market Time |
1,783,972,801 |
| Regular Market Volume |
15,162 |
| Return On Assets |
-0.39536 |
| Return On Equity |
-6.65567 |
| Revenue Growth |
-0.841 |
| Revenue Per Share |
0.04 |
| Sand P52 Week Change |
0.20847368 |
| Sector |
Healthcare |
| Sector Disp |
Healthcare |
| Sector Key |
healthcare |
| Shares Outstanding |
7,018,528 |
| Shares Percent Shares Out |
0.005 |
| Shares Short |
35,140 |
| Shares Short Previous Month Date |
1,780,012,800 |
| Shares Short Prior Month |
77,671 |
| Short Name |
Vyome Holdings, Inc. |
| Short Percent Of Float |
0.0078 |
| Short Ratio |
1.63 |
| Source Interval |
15 |
| State |
MA |
| Symbol |
HIND |
| Target High Price |
15.0 |
| Target Low Price |
8.0 |
| Target Mean Price |
11.5 |
| Target Median Price |
11.5 |
| Total Cash |
8,795,783 |
| Total Cash Per Share |
1.253 |
| Total Debt |
22,548 |
| Total Revenue |
152,724 |
| Tradeable |
0 |
| Trailing Annual Dividend Rate |
0.0 |
| Trailing Annual Dividend Yield |
0.0 |
| Trailing Eps |
-1.55 |
| Trailing Peg Ratio |
None |
| Triggerable |
1 |
| Two Hundred Day Average |
3.344285 |
| Two Hundred Day Average Change |
-1.104285 |
| Two Hundred Day Average Change Percent |
-0.3302006 |
| Type Disp |
Equity |
| Volume |
15,162 |
| Website |
https://www.vyometx.com |
| Zip |
2,138 |